The local organizer of an international AIDS conference in Montreal says the event has helped highlight the enormous progress that has been made in HIV research and treatment technology.
Dr. Jean-Pierre Routy, local chair of the conference, says the biggest breakthrough presented was research showing that a single injection of a long-lasting antiretroviral medication can prevent people from acquiring an HIV infection for two months, replacing daily pills.
Despite visa issues that prevented hundreds of delegates from attending, Routy says that people from 172 countries were present at the event, which ends Tuesday.
But Tinashe Rufurwadzo, the director of programs, management and governance at Y+ Global, an international organization of HIV-positive youth, says the AIDS 2022 conference was bittersweet.
He says that those attending were able to have meetings that might not otherwise be possible, such as with government officials and pharmaceutical executives, but many voices were missing because of the visa issues.
- Saskatchewan Premier Scott Moe talks trade at international conference
- Thieves cut hole in roof at Kelowna Curling Club in elaborate break-in, theft
- Calgary’s GlobalFest moving locations, leaving community in lurch
- Progress slows on Calgary housing strategy due to rezoning repeal, resource constraints
-
![]()
Canadian government short on rolling back international student permits, report reveals -
![]()
U.S., Russia interfering in Alberta separatist debate, report says -
![]()
Canadians can trust ChatGPT to handle personal data, federal privacy watchdog says after review -
![]()
Social media issues should be fixed before considering ban for youth: Canada’s privacy commissioner
Get weekly health news
More than 9,000 people were scheduled to attend in person, with another 2,000 people registered to take part online.
Comments
Want to discuss? Please read our Commenting Policy first.